Please assess the completion status of the following clinical trial:

Trial Title: Comparison Between Symbicort® and Prednisolone in COPD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with chronic obstructive pulmonary disease and an acute exacerbation~* After the acute treatment a simple pulmonary function test shows a value of 30%-60% of the predicted normal value.~* Patients, who, based on the clinical examination after the initial acute treatment, are candidates for a course of oral steroids for the treatment of acute symptoms due to chronic obstructive pulmonary disease~Exclusion Criteria:~* Diagnosis/history of asthma~* Oxygen uptake (saturation) is \<92% after the initial acute treatment~* A requirement for regular use of oxygen therapy~* Regular treatment with any inhaled steroid \>1 000 µg/day at study entry~Additional inclusion and exclusion criteria will be evaluated by the investigator

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).